Overall, due to the limited functionality of CYP17A1 in the prostate cancer models, C21 steroids are more abundant than the C19 steroids, and alternative pathways could contribute to prostatic steroidogenesis. The gene discussed is CYP17A1; the disease is prostate carcinoma.